<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 21-year-old man had been diagnosed as having <z:mp ids='MP_0005048'>thrombosis</z:mp> of the dural sinus secondary to <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease </plain></SENT>
<SENT sid="1" pm="."><plain>Despite treatment with acetozolamide, <z:chebi fb="2" ids="2948">azathioprine</z:chebi> and <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> over the ensuing 6 months, he had little improvement in his symptoms of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> and required frequent lumbar <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CFS</z:e> drainage </plain></SENT>
<SENT sid="2" pm="."><plain>The patient then underwent lumboperitoneal shunt operation, which resulted in rapid resolution of <z:hpo ids='HP_0001085'>papilledema</z:hpo> and gradual improvement in the visual field </plain></SENT>
<SENT sid="3" pm="."><plain>In conclusion, we suggest that in BD patients with dural sinus <z:mp ids='MP_0005048'>thrombosis</z:mp>, in whom the intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> developed but failed to normalize after treatment with <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi>, lumboperitoneal shunting should be considered as an effective therapeutic tool </plain></SENT>
</text></document>